alexa Squamous Cell Carcinoma in Barretts Esophagus | OMICS International
ISSN: 2161-069X
Journal of Gastrointestinal & Digestive System
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Squamous Cell Carcinoma in Barretts Esophagus

Esteban Trakál1*, Juan José Trakál1, Abel L. L. Butti1, Fabián E. Zárate1, Andrés Guidi2 and Rubén Sambuelli2

1Department of Gastroenterology, Reina Fabiola Clinic, School of Medicine, Catholic University of Córdoba, Argentina

2Department of Pathology, Reina Fabiola Clinic, School of Medicine, Catholic University of Córdoba, Argentina

*Corresponding Author:
Esteban Trakal
Department of Gastroenterology
Reina Fabiola Clinic, School of Medicine
Catholic University of Córdoba, Argentina
E-mail: [email protected]

Received date: April 17, 2013; Accepted date: June 20, 2013; Published date: June 22, 2013

Citation: Trakál E, Trakál JJ, Butti ALL, Zárate FE, Guidi A, et al. (2013) Squamous Cell Carcinoma in Barrett’s Esophagus. J Gastroint Dig Syst S12:018. doi: 10.4172/2161-069X.S12-018

Copyright: © 2013 Trakál E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Gastrointestinal & Digestive System

Abstract

Barrett’s esophagus (BE), consequence of chronic gastroesophageal reflux disease (GERD), is a pre-malignant condition, capable of turning into adenocarcinoma (ACa). However the presence of squamous cell carcinoma (SCa) coexisting with Barrett’s metaplasia, is reported in some papers. The aim of this paper is to present 17 patients involving synchronous BE and SCa.

Keywords

Barrett’sesophagus; Adenocarcinoma; Squamous carcinoma

Introduction

Barrett’s esophagus (BE), according with the Montreal Consensuscriteria [1], is defined as columnar metaplasia lining the distal esophagus, with specialized intestinal metaplasia with goblet cells (IM+), or gastric metaplasia with cardial type or fundic-oxyntic type mucosa (GM+).

It is a pre-malignant condition with an increased risk of adenocarcinoma (ACa). Only IM develop ACa. No cancer was found in other types of columnar mucosa [2-4]. All the same, non-goblet columnar metaplasia of the esophagus could progress to cancer, but the magnitude of risk is unknown [2].

However, we found some papers in which squamous or adenosquamous carcinoma develops jointly with Barrett’s mucosa instead of ACa [5-23].

Materials and Methods

All patients were diagnosed by means of upper endoscopy, and multiple biopsies were performed in the Barrett’s mucosa and all visible lesions. The appearance and measurement of the metaplasia are classified according to C&M Prague Criteria [2,24].

Patients examined previously to the existence of these criteria, were reviewed and reclassified according to the present nomenclature.

At least 2 experienced gastrointestinal pathologists should evaluate all biopsies in order to avoid interobserver variation [2,25].

Patients

From January 1982 upto January 2013, 1424 BE were diagnosed. Which 501 had IM+, and 923 GM+. ACa developed in 67 patients and squamous cell carcinoma (SCa) in 17. Two patients had simultaneously both types of cáncer.

Results

In Table 1, we expose date of diagnosis, patients identification with the record number, sex, age, Prague C&M criteria, location and gross appearance.

Date Patient Sex Age Prague C&M Esophageal location Gross appearance
7/8/08 470 AT F 67 M1 middle mass
30/10/96 159 AJ M 52 C1 middle ulcerative
15/5/96 125 BJ F 72 C3 distal ulcerative
23/4/97 168 GA M 54 C1 middle mass
22/5/87 38 GPI M 64 M3 middle mass
28/3/96 121 LF M 58 C3 distal mass
31/10/96 161 MJF M 72 C1 middle ulcerative
30/10/98 195 MV M 76 C3 middle+distal (SCa+ACa) mass
26/7/00 219 OF M 63 C2 distal mass
12/9/96 145 OT M 58 C2 middle infiltrative
9/8/94 86 PH M 63 M3 distal infiltrative
8/2/94 81 LC M 32 C9 middle ulcerative
10/10/96 149 QD F 83 C1 middle+distal(SCa+ACa) mass
7/10/02 464 RJ M 59 C6 distal mass
13/9/02 463 RE M 55 C3 distal infiltrative
7/2/96 116 RME F 71 C6 distal infiltrative
11/10/02 465 TB M 81 C4 distal infiltrative

Table 1: Squamous cell carcinoma in Barrett’s esophagus.

The great majority (13 patients) were male. The average age was 58.23 years old (Min 32, Max 81). Among women (4 patients), the average age was 73.25 years old (Min 67, Max 83).

According to Prague C&M criteria, only 3 were tongue-shaped (M) and 14 circumferential (C). With reference to the length, 7 were short (less than 3 cm) and 10 were long (3 cm or more).

Nine of the SCa were located in the middle esophagus with a free space of malignant tissue reaching columnar metaplasia. In 2 of them ACa in Barrett’s mucosa was synchronous with SCa, in the remaining cases, neither tumor nor displasia were found. While the other 8 SCa, had evolved into distal esophagus nearby columnar metaplasia.

The gross appearance during endoscopy was of three types: mass, ulcerative or infiltrative. Varying strictures were present in all cases.

Discussion

It is known that the natural history evolves from GERD through Barrett’s esophagus to ACa. But occasionally papers report that other types of cáncer, mostly squamous or adenosquamous carcinoma, can appear related to BE [5,23].

This reminds us that Barrett’s esophagus is a mosaic of metaplasia, dysplasia and neoplasia, showing variable degrees of architectural and cell changes in the intestinal and gastric epithelium lining the esophagus [26]. So why would not it be posible for Barret´s esophagus to turn into SCa instead of ACa? We should not forget, that BE is a consequence of long-term gastro-esophageal reflux disease [27].

Various kinds of refluxed material cause different types of lesions, including ulcers, strictures, metaplasia, dysplasia, and cáncer [5,21,28].

ACa in Barrett’s is developed on IM. Failure in detection of ACa in biopsies cannot be interpreted as absence of it, as a result of the patchy appearance it may adopt [26,29].

In our series of 923 GM+, no cáncer was found in gastric-fundic or cardial columnar mucosa. Both type of cancer (ACa and SCa) were developed in esophagus with IM.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11830
  • [From(publication date):
    specialissue-2013 - Dec 15, 2017]
  • Breakdown by view type
  • HTML page views : 8071
  • PDF downloads : 3759
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version